跳转至内容
Merck
CN

SML3504

AM-2201

≥98% (HPLC)

别名:

1-(5-Fluoropentyl)-3-(1-naphthoyl) indole, AM 2201, JWH 2201, [1-(5-Fluoropentyl)-1H-indol-3-yl]-1-naphthalenylmethanone

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C24H22FNO
化学文摘社编号:
分子量:
359.44
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Level

assay

≥98% (HPLC)

form

powder

drug control

USDEA Schedule I; Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet, kontrollierte Droge in Deutschland

color

white to beige

solubility

DMSO: 2 mg/mL, clear

shipped in

wet ice

storage temp.

-10 to -25°C

SMILES string

O=C(C1=CC=CC2=C1C=CC=C2)C3=CN(C4=CC=CC=C43)CCCCCF

InChI

1S/C24H22FNO/c25-15-6-1-7-16-26-17-22(20-12-4-5-14-23(20)26)24(27)21-13-8-10-18-9-2-3-11-19(18)21/h2-5,8-14,17H,1,6-7,15-16H2

InChI key

ALQFAGFPQCBPED-UHFFFAOYSA-N

Biochem/physiol Actions

Potent agonist at both CB1 and CB2 with moderate selectivity for CB1
AM-2201 is a potent agonist at both CB1 and CB2 with moderate selectivity for CB1, with a Ki of 1.0nM at CB1 and 2.6nM at CB2. AM-2201 is more potent than phytocannabinoid Δ9-tetrahydrocannabinol.

Legal Information

German
Dieses Produkt fällt unter das Betäubungsmittelgesetz (BtMG). Für eine Bestellung dieses Produktes ist eine Erlaubnis nach § 3 BtMG zwingend erforderlich, es sei denn, es greift eine Ausnahme von der Erlaubnispflicht nach § 4 oder § 26 BtMG.

English
This product is subject to the German Narcotics Act. A permit under Section 3 of the German Narcotics Act is mandatory for ordering this product unless an exemption from the permit requirement under Section 4 or Section 26 of the German Narcotics Act applies.


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

STOT SE 3

target_organs

Central nervous system

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

监管及禁止进口产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Stefan Kneisel et al.
Journal of mass spectrometry : JMS, 47(7), 825-835 (2012-07-14)
The analysis of synthetic cannabinoids in human matrices is of particular importance in the fields of forensic and clinical toxicology since cannabis users partly shift to the consumption of 'herbal mixtures' as a legal alternative to cannabis products in order
Jeremy Carlier et al.
The Journal of pharmacology and experimental therapeutics, 367(3), 543-550 (2018-09-30)
Novel synthetic cannabinoids are appearing in recreational drug markets worldwide. Pharmacological characterization of these new drugs is needed to inform clinicians, toxicologists, and policy makers who monitor public health. [1-(5-Fluoropentyl)-1H-indol-3-yl](1-naphthyl)methanone (AM-2201) is an abused synthetic cannabinoid that was initially created
New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites.
Xingxing Diao
Frontiers in Chemistry, 7, 109-109 (2019)



全球贸易项目编号

货号GTIN
SML3504-25MG04065269025931
SML3504-5MG04065269025948